recurr
whether
cdi
resolv
whether
cdi
nosocomialhospit
commun
acquir
techniqu
diagnost
algorithm
use
cdi
hospit
chosen
high
costeffect
detect
glutam
dehydrogenas
antigen
clostridium
difficil
toxin
immunochromatographi
immunocard
c
difficil
gdh
meridian
bioscienc
inc
cincinnati
oh
usa
faec
confirm
cd
toxin
product
mainli
tcdb
molecular
biolog
techniqu
illumigen
grifol
pcr
lampcincinnati
oh
usa
subsequ
realtim
pcr
db
max
system
bectondickinson
md
usa
patient
male
femal
mean
age
distribut
tumour
diseas
divers
patient
treat
oral
metronidazol
h
patient
recur
diarrhoea
treat
oral
vancomycin
h
day
evid
bi
two
recur
case
lack
respons
use
oral
vancomycin
treat
intraven
metronidazol
h
obtain
complet
respons
diarrhoea
analysi
variabl
clinic
respons
tabl
noteworthi
use
metronidazol
treatment
earli
subsequ
recurr
effect
seri
patient
current
recommend
initi
earli
recurr
treat
oral
vancomycin
h
day
bi
patient
studi
three
admit
two
treat
first
recurr
oral
vancomycin
later
intraven
metronidazol
obtain
complet
respons
case
purpos
commun
main
interest
lie
cancer
patient
good
respons
metronidazol
clinic
variabl
evalu
studi
reflect
associ
prior
antibiot
treatment
use
protonpump
inhibitor
cdi
human
metapneumoviru
hmpv
first
describ
respiratori
secret
although
previou
serolog
studi
show
alreadi
circul
human
sinc
hmpv
respons
acut
respiratori
infect
ari
present
worldwid
season
distribut
predomin
winter
mainli
affect
children
year
age
make
second
viral
caus
rsv
ari
caus
hmpv
adult
rare
entiti
incid
valu
similar
describ
rsv
lower
influenza
virus
winter
season
although
ari
caus
hmpv
adult
asymptomat
clinic
manifest
may
high
morbid
mortal
nurs
home
among
elderli
gener
report
prospect
studi
ari
caus
hmpv
adult
year
age
period
januari
march
throat
swab
taken
patient
came
emerg
room
suspect
ari
detect
presenc
respiratori
virus
diagnost
techniqu
use
commerci
pcrtype
genom
amplif
real
time
allplex
tm
respiratori
panel
seegen
seoul
south
korea
medic
record
epidemiolog
data
patient
hmpv
respiratori
sampl
review
studi
analyz
patient
consid
posit
respiratori
virus
hmpv
detect
case
posit
patient
case
account
hmpv
detect
studi
paediatr
popul
regard
sex
distribut
women
averag
age
year
rang
year
coinfect
respiratori
virus
rhinoviru
adenoviru
detect
case
case
detect
month
februari
april
patient
studi
requir
hospit
admit
intens
care
unit
patient
die
consequ
respiratori
infect
associ
hmpv
main
clinic
symptom
diseas
shown
tabl
patient
receiv
antibiot
treatment
clavulan
acid
levofloxacin
patient
consid
immunosuppress
one
predispos
factor
percentag
hmpv
detect
studi
similar
alreadi
report
larger
studi
compar
virus
caus
ari
adult
popul
geograph
area
observ
incid
rsv
coronaviru
bocaviru
tabl
main
symptom
diseas
detect
patient
infect
human
metapneumoviru
fever
among
respiratori
diseas
hmpv
describ
caus
pneumonia
bronchiti
tracheobronch
respiratori
distress
condit
pneumonia
repres
main
diseas
associ
hmpv
studi
follow
bronchiti
tracheobronch
respect
frequenc
hospit
rang
depend
age
condit
patient
group
intens
care
unit
percentag
much
higher
ari
caus
rsv
coronaviru
bocaviru
ari
caus
hmpv
appear
affect
mainli
adult
popul
underli
diseas
asthma
copd
chronic
heart
diseas
present
patient
besid
ailment
typic
age
includ
hypertens
diabet
mellitu
patient
consid
immunocompromis
affect
leukaemia
lymphoma
one
colon
cancer
sinc
specif
antivir
hmpv
treatment
prevent
possibl
bacteri
superinfect
patient
receiv
antibiot
treatment
amoxicillinclavulan
acid
levofloxacin
mild
moder
natur
respiratori
infect
caus
hmpv
studi
could
determin
absenc
death
associ
viru
